PLIANT THERAPEUTICS, INC. Revenue Breakdown
No Revenue Breakdown for PLRX on this site yet.
- 2025-12-31: Total revenue $0.00.
- 2024-12-31: Total revenue $0.00.
- 2023-12-31: Others Not split by product in the filing$1.58M100.00%; Total revenue $1.58M.
- 2022-12-31: Others Not split by product in the filing$9.69M100.00%; Total revenue $9.69M.
Source checked: the stored Revenue Breakdown page for PLRX.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | $0.00 | |
| 2024-12-31 | $0.00 | |
| 2023-12-31 | Not split by product in the filing $1.58M 100.00% | $1.58M |
| 2022-12-31 | Not split by product in the filing $9.69M 100.00% | $9.69M |
| 2021-12-31 | Not split by product in the filing $7.57M 100.00% | $7.57M |
| 2020-12-31 | Not split by product in the filing $41.82M 100.00% | $41.82M |
| 2019-12-31 | Not split by product in the filing $57.05M 100.00% | $57.05M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2024-12-31 | Not split by product $0.00 | $0.00 |
| 2024-09-30 | Not split by product $0.00 | $0.00 |
| 2024-06-30 | Not split by product $0.00 | $0.00 |
| 2024-03-31 | Not split by product $0.00 | $0.00 |
| 2023-12-31 | Not split by product $0.00 | $0.00 |
| 2023-09-30 | Not split by product $0.00 | $0.00 |
| 2023-06-30 | Not split by product $248.00K 100.00% | $248.00K |
| 2023-03-31 | Not split by product $1.33M 100.00% | $1.33M |
| 2022-12-31 | Not split by product $1.97M 100.00% | $1.97M |
| 2022-09-30 | Not split by product $1.48M 100.00% | $1.48M |
| 2022-06-30 | Not split by product $4.99M 100.00% | $4.99M |
| 2022-03-31 | Not split by product $1.25M 100.00% | $1.25M |
| 2021-12-31 | Not split by product $2.00M 100.00% | $2.00M |
| 2021-09-30 | Not split by product $1.61M 100.00% | $1.61M |
| 2021-06-30 | Not split by product $1.79M 100.00% | $1.79M |
| 2021-03-31 | Not split by product $2.17M 100.00% | $2.17M |
| 2020-12-31 | Not split by product $4.46M 100.00% | $4.46M |
| 2020-09-30 | Not split by product $4.81M 100.00% | $4.81M |
| 2020-06-30 | Not split by product $3.60M 100.00% | $3.60M |
| 2020-03-31 | Not split by product $28.94M 100.00% | $28.94M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |